Highpoint Pharmaceuticals LLC - 10%+ Owner at Tharimmune, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
THAR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Highpoint Pharmaceuticals LLC since 08 Feb 2025

Holdings reported by Highpoint Pharmaceuticals LLC for Tharimmune, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 972,222 $489,028 $0.5030 11 Jan 2022 Direct

There are no transactions reported by Highpoint Pharmaceuticals LLC for Tharimmune, Inc.